Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03501992 · ClinicalTrials.gov registry record · NA
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 9,242
- Enrollment target
NCT03501992: Completed NA study, sponsored by Mayo Clinic.
NCT03501992 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 9,242 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03501992, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 9,242 participants
- Enrollment target
Study Summary
Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been disappointingly low and lags behind other adolescent vaccines. This study seeks to test interventions targeting health care system, provider, and patient factors to improve the population uptake of the HPV vaccine.
Interventions
- BEHAVIORAL Audit-and-feedback
- BEHAVIORAL Current care
- BEHAVIORAL Reminder-recall
- BEHAVIORAL Combined reminder-recall and audit-and-feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,242 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03501992
The ClinicalTrials.gov registry entry for NCT03501992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9,242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Audit-and-feedback is the first listed.
NCT03501992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03501992 about?
NCT03501992 is a clinical study titled "Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination". Each year the human papillomavirus (HPV) causes 30,000 cancers in the United States despite the availability of very effective and safe vaccines. Uptake of the HPV vaccine has been disappointingly low and lags behind other adolescent vaccines. This study seeks to test interventions targeting health ...
What is the current status of trial NCT03501992?
This trial is currently completed. It is a NA study. The enrollment target is 9,242 participants. The study started on 2018-04-01. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT03501992?
The interventions under investigation include: Audit-and-feedback (BEHAVIORAL), Current care (BEHAVIORAL), Reminder-recall (BEHAVIORAL), Combined reminder-recall and audit-and-feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03501992?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.